IL3RA and neoplasm: In this study, we have demonstrated that anti-IL-3R-EVs also reduce β-catenin expression in tumor-bearing mice, suggesting that anti-IL-3R-EVs are also able to target the canonical wingless Wnt/β-catenin pathway in neoplastic cells.